CHEK1 and breast cancer: lncRNA CASC9 positively regulated checkpoint kinase 1 (CHK1) by competitively binding to the miR-195/497 cluster, thereby accelerated BC cell proliferation, accelerated cell cycle progression, and inhibited cell apoptosis (49).